Cargando…

Pulmonary vascular and cardiac impairment in interstitial lung disease

Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Panagiotou, Marios, Church, Alistair C., Johnson, Martin K., Peacock, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488566/
https://www.ncbi.nlm.nih.gov/pubmed/28096284
http://dx.doi.org/10.1183/16000617.0053-2016
_version_ 1784792686734082048
author Panagiotou, Marios
Church, Alistair C.
Johnson, Martin K.
Peacock, Andrew J.
author_facet Panagiotou, Marios
Church, Alistair C.
Johnson, Martin K.
Peacock, Andrew J.
author_sort Panagiotou, Marios
collection PubMed
description Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management.
format Online
Article
Text
id pubmed-9488566
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-94885662022-11-14 Pulmonary vascular and cardiac impairment in interstitial lung disease Panagiotou, Marios Church, Alistair C. Johnson, Martin K. Peacock, Andrew J. Eur Respir Rev Reviews Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management. European Respiratory Society 2017-01-18 /pmc/articles/PMC9488566/ /pubmed/28096284 http://dx.doi.org/10.1183/16000617.0053-2016 Text en Copyright ©ERS 2017. https://creativecommons.org/licenses/by-nc/4.0/ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Reviews
Panagiotou, Marios
Church, Alistair C.
Johnson, Martin K.
Peacock, Andrew J.
Pulmonary vascular and cardiac impairment in interstitial lung disease
title Pulmonary vascular and cardiac impairment in interstitial lung disease
title_full Pulmonary vascular and cardiac impairment in interstitial lung disease
title_fullStr Pulmonary vascular and cardiac impairment in interstitial lung disease
title_full_unstemmed Pulmonary vascular and cardiac impairment in interstitial lung disease
title_short Pulmonary vascular and cardiac impairment in interstitial lung disease
title_sort pulmonary vascular and cardiac impairment in interstitial lung disease
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488566/
https://www.ncbi.nlm.nih.gov/pubmed/28096284
http://dx.doi.org/10.1183/16000617.0053-2016
work_keys_str_mv AT panagiotoumarios pulmonaryvascularandcardiacimpairmentininterstitiallungdisease
AT churchalistairc pulmonaryvascularandcardiacimpairmentininterstitiallungdisease
AT johnsonmartink pulmonaryvascularandcardiacimpairmentininterstitiallungdisease
AT peacockandrewj pulmonaryvascularandcardiacimpairmentininterstitiallungdisease